To simulate the clinical stages of ALL, we treated the mice with the menin inhibitor SNDX-50469, which we previously showed induced extended remissions of MLL-r ALL PDXs followed by highly reproducible disease relapse or cure in several mice [20]. Here, KMT2A is linked to acute lymphoblastic leukemia.